Company / Gross Profit per Share
Harmony Biosciences Holdings, Inc. Gross Profit per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$11.73
FY2025
5-year range
$0.08 / $11.73
FY2021-FY2025
Trend
+19.3%
vs FY2024
Sector context
#6 of 29
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s gross profit per share of $11.73 is higher than 79% of companies in the Health Care sector (FY2025). Gross Profit per Share has increased for 4 consecutive years, from $0.08 in FY2021 to $11.73 in FY2025.
Based on SEC 10-K filings.
11.73 in FY2025 with a 5-year CAGR of +83.3%. Top quartile in the Health Care sector.
Improved from $7.73 to $11.73 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +24.9%
- 5-Year CAGR
- +83.3%
- 10-Year CAGR
- -
Sector benchmark
+44.6% above sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s gross profit per share has grown for 4 consecutive years.
- In FY2025, gross profit per share increased 19.3% year-over-year.
- Ranks #6 out of 29 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.73 | +19.3% |
| FY2024 | $9.83 | +27.2% |
| FY2023 | $7.73 | +28.3% |
| FY2022 | $6.02 | +7657.3% |
| FY2021 | $0.08 | -86.3% |
| FY2020 | $0.57 | -0.1% |
| FY2019 | $0.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026